Floxuridine

Catalog No.S1299 Synonyms: Deoxyfluorouridine, FDUR, NSC 27640

Floxuridine Chemical Structure

Molecular Weight(MW): 246.19

Floxuridine is an antineoplastic antimetabolite, used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.

Size Price Stock Quantity  
USD 97 In stock
USD 297 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Floxuridine is an antineoplastic antimetabolite, used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.
In vitro

Floxuridine exhibits higher affinity for PEPT1 than the corresponding 5'-O-mono amino acid ester prodrugs. [1] Floxuridine combined with Leucovorin results in synergistic inhibitory effects on growth of human T-lymphoblast leukemia cells. [2] Floxuridine significantly inhibits the uptake of both [(3)H]-inosine and [(3)H]-adenosine (60-70% of control), while its amino acid ester prodrugs including Val, Phe, Pro, Asp, and Lys esters exhibits markedly decreased inhibition potency (10-30% of control). [3] Floxuridine inhibits cell proliferation by more than 50% relative to the untreated control cells at 36 days, the cell numbers still increases fourfold compared with the initial cell density. Floxuridine results in prolonged effects on the proliferation of human Tenon's capsule fibroblasts in vitro. [4] Floxuridine (FUDR) is an ideal drug for hepatic arterial infusion (HAI) due to its short half life, steep dose response curve, high total body clearance, and high hepatic extraction. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CCRF-CEM cell M2PtTWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NUm1UXBkXGW|dHXkJIlvKH[rdILvJIZweiC2aHWgbY5pcWKrdHnvckBw\iClZXzsJIdzd3e2aDDv[kBpfW2jbjDUJIx6dXCqb3LsZZN1d2mmIFPDVmYuS0WPIHPlcIwhdGmwZTCoRXRESyCFQ1ygNVE6MSxiSVO1NF0xNjVizszN NFrafWYyOTlyOUexOi=>
CCRF-CEM MWrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NVnC[FltUW5idnn0do8h[2:wY3XueJJifGmxbjDy[ZF2cXKnZDDmc5IhPTBnIHnubIljcXSrb36gc4Yh\3Kxd4ToJI9nKGi3bXHuJIxmfWunbXnhJINmdGxibHnu[UBES1KILVPFUUB4cXSqIHjQRXAhMDBwMjD1col1N22OKTygS2k2OD1yLkCwNFYh|ryP NHHTbmwyOTV7N{SwOC=>
LNCaP cells Mm\wR5l1d3SxeHnjbZR6KGG|c3H5 MXzDfZRwfG:6aXOgZ49v[2WwdILheIlwdiCrbjDwdo9{fGG2ZTDzdIVkcW[rYzDhcpRq\2WwIDjQV2EqKHC{b3T1Z4lv\yCqdX3hckBNVkOjUDDj[YxteyxiSVO1NF0xNjB4OUKg{txO M4LRNlEzOTZzMUW3
TSU cells NX[2N3h1S3m2b4TvfIlkcXS7IHHzd4F6 MV\DfZRwfG:6aXOgZ49v[2WwdILheIlwdiCrbjDuc44heHKxc4TheIUhe3CnY3nmbYMh[W62aXflckApWFODKTDwdo9lfWOrbnegbJVu[W5iVGPVJINmdGy|LDDJR|UxRTBwMEW4JO69VQ>? MUixNlE3OTF3Nx?=
KBALB cell MWHDfZRwfG:6aXPpeJkh[XO|YYm= Mn\FTY4hfmm2cn:gZ4VtdCCleYTveI95cWOrdImgZYdicW6|dDDLRmFNSiClZXzsJIxqdmViKITyZY5{\m:{bXXkJIZq[nKxYnzhd5Qhe2G{Y3;tZUBk\WyuIHzpcoUqNCCFQ{WwQVYvODCHLUC1JO69VQ>? NUX5dmp5OTJ4MkCwO|Y>
KBALB-STK cell M1;hTmN6fG:2b4jpZ4l1gSCjc4PhfS=> NHjLVIVKdiC4aYTyc{Bk\WyuIHP5eI91d3irY3n0fUBi\2GrboP0JGtDSUyELWPUT{Bk\WyuIHzpcoV{KGW6cILld5Nm\CCrbjDIV3YuOSCWSzygTWM2OD16LkiwSU0xPSEQvF2= MX6xNlYzODB5Nh?=
L1210 mouse leukemia cells MY\Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NVfxd45QOjRiaB?= NEnTZXpIem:5dHigbY5pcWKrdHnvckBqdiCOMUKxNEBud3W|ZTDs[ZVs\W2rYTDj[YxteyCjZoTldkAzPCCqIITy[YF1dWWwdDygTWM2OD1yLkCwOFEh|ryP MmLSNVE4OjhzOUO=
L1210 mouse leukemia cells M163Umdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 M17oelQ5KGh? MVfHdo94fGhiaX7obYJqfGmxbjDpckBNOTJzMDDtc5V{\SCuZYXr[Y1q[SClZXzsd{Bi\nSncjC0PEBpeiC2cnXheI1mdnRuIFnDOVA:OC5yMEC2OEDPxE1? M4[0Z|EyPzJ6MUmz
L5178Y cell NGfhVGlIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MonoR49ueGG{YYTpeoUhcW6qaXLpeIlwdiCxZjDMOVE4QFliY3XscEBoem:5dHigbY4hfmm2cn:gLINwdmOnboTyZZRqd25icnXxeYlz\WRiZn;yJFUxLSCrbnjpZol1cW:wKTygTWM2OD1yLkCwNFc3KM7:TR?= M4jZ[|Y4PzlyMEe=
L5178Y cells M3fXbWZ2dmO2aX;uJIF{e2G7 MWPJcohq[mm2b4L5JINwdmOnboTyZZRqd25ib3[gZ49ueG:3bnSge4F{KGOjbHP1cIF1\WRib36gUFUyPzi\IHPlcIx{KGK7IGuxOGNeVGW3IHnuZ49zeG:{YYTpc44tKEmFNUC9NkDPxE1? NFjCT|g5OjR4MkK5
L1210 mouse leukemia cells M13pW2Z2dmO2aX;uJIF{e2G7 M4f3ZVIhcA>? NYjLeXNTXGi7bXnkfYxifGVic4nueIhie2ViaX7obYJqfGmxbjDpckBNOTJzMDDtc5V{\SCuZYXr[Y1q[SClZXzsd{Bi\nSncjCyJIhzKHS{ZXH0cYVvfCxiSVO1NF0xNjByN{mg{txO NXq3O4tHOTF5MkixPVM>
LM cells NVXrXFlVTnWwY4Tpc44h[XO|YYm= NIj6TpUzKGh? MmjIWIh6dWmmeXzheIUhe3mwdHjhd4UhcW6qaXLpeIlwdiCrbjD0bJlucWSrbnWgb4lv[XOnIHTl[olkcWWwdDDMUUBk\WyuczDh[pRmeiB{IHjyJJRz\WG2bXXueEwhUUN3ME21MlQh|ryP Mn\vNVE4OjhzOUO=
HT1080 cells M1e4XmZ2dmO2aX;uJIF{e2G7 NFnrbHZEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTHQyODhyIHPlcIx{KGK7IF3UWEBie3OjeTygTWM2OD1yLkG4JO69VQ>? NHv2[5QyPzhyNEKzNS=>
L1210 cells MlL6S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MVq3NkBp M2WweGN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDMNVIyOCClZXzsd{BCXEOFIFPDUFIyQSCjc4Pld5Nm\CCjczDndo94fGhicnXkeYN1cW:wIHHmeIVzKDd{IHjyd{whUUN3ME2wMlAyOiEQvF2= M3rlNlE4QTl5M{G5
HL60 cells NIrndpNIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NY\DZopwPzJiaB?= NGnXcmhEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTGw3OCClZXzsd{BCXEOFIFPDUEAzPDBiYYPz[ZN{\WRiYYOg[5Jwf3SqIILl[JVkfGmxbjDh[pRmeiB5MjDodpMtKEmFNUC9NE4xOTJizszN NHj3T2cyPzl7N{OxPS=>
CCRF-CEM cells MkfRS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M4TSclczKGh? MVfDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1PSSk1ETU1iY3XscJMhSVSFQzDDR2whOTF7IHHzd4V{e2WmIHHzJIdzd3e2aDDy[YR2[3Srb36gZYZ1\XJiN{KgbJJ{NCCLQ{WwQVAvODF5IN88US=> M1vpNlE4QTl5M{G5
L1210 cells M3nMdWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 M3nWTVczKGh? MX\DfZRwe3SjdHnjJIFkfGm4aYT5JIlvKG2xdYPlJGwyOjFyIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDndo94fGhiYX\0[ZIhPzJiaILzMEBKSzVyPUCuNFEzKM7:TR?= MYOxPFA4QDd3Nx?=
HL60 cells MlzVS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NIDsTlc4OiCq NF;D[2dEgXSxc4TheIlkKGGldHn2bZR6KGmwIHj1cYFvKEiONkCgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iClZXzsJIdzd3e2aDDh[pRmeiB5MjDodpMtKEmFNUC9NE4xOTJizszN MVWxPFA4QDd3Nx?=
CCRF-CEM cells NXnuR3p4T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MmPUO|IhcA>? Ml\CR5l1d3O2YYTpZ{Bi[3Srdnn0fUBqdiCqdX3hckBES1KILVPFUUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHPlcIwh\3Kxd4ToJIFnfGW{IEeyJIhzeyxiSVO1NF0xNjBzNzFOwG0> NEPRcnAyQDB5OEe1Oy=>
CCRF-CEM cells M4HoN2Z2dmO2aX;uJIF{e2G7 MorWOFghcA>? MXnBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1PSSk1ETU1iY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yME[zNUDPxE1? NVq5cm1uOTl5NES4OVg>
K562 cells M{DaXGZ2dmO2aX;uJIF{e2G7 MYe0PEBp NFzhXllCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gT|U3OiClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjd7NEOzJO69VQ>? NXjLc3lMOTl5NES4OVg>
MOLT4 cells MVPGeY5kfGmxbjDhd5NigQ>? M37aPVQ5KGh? NVLU[GliSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG1QVFR2IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMEO5PFEh|ryP MVKxPVc1PDh3OB?=
RPMI8266 cells NH\GUGhHfW6ldHnvckBie3OjeR?= M32wXlQ5KGh? NGqw[IhCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVnBOUTh{Nk[gZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD63PVQ{OyEQvF2= NXX2XHFWOTl5NES4OVg>
human SR cells NF7QUI1HfW6ldHnvckBie3OjeR?= MmPSOFghcA>? M3\JSGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTVkBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlAyOjV7IN88US=> MXOxPVc1PDh3OB?=
A549 cells MnniSpVv[3Srb36gZZN{[Xl? MkjqOFghcA>? MUHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUW0PUBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlAyOjV7IN88US=> NF;xWWwyQTd2NEi1PC=>
EKVX cells M1vZTmZ2dmO2aX;uJIF{e2G7 MlmwOFghcA>? NXrrUWVpSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGVMXlhiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OTBizszN MkfwNVk4PDR6NUi=
HOP62 cells NX7a[YhxTnWwY4Tpc44h[XO|YYm= NITOboQ1QCCq NXK5[GM2SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhQWDZ{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMEK1NVIh|ryP NIXQNoMyQTd2NEi1PC=>
HOP92 cells MkDySpVv[3Srb36gZZN{[Xl? NXjmOZRFPDhiaB?= MoLBRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjPVFkzKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvPzl2M{Og{txO NGnFSoIyQTd2NEi1PC=>
NCI-H226 cells MXrGeY5kfGmxbjDhd5NigQ>? NET6dIQ1QCCq Mm\GRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7DTU1JOjJ4IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7 MXKxPVc1PDh3OB?=
NCI-H23 MmjFSpVv[3Srb36gZZN{[Xl? NFHkTIg1QCCq MY\BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTlPJMWgzOyClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yOCEQvF2= M4nEVVE6PzR2OEW4
NCI-H322 M2PXc2Z2dmO2aX;uJIF{e2G7 MYC0PEBp NFvnWXlCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh|MkLNJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuOVAyOTlizszN NYXFVItFOTl5NES4OVg>
NCI-H460 MVnGeY5kfGmxbjDhd5NigQ>? Mlz5OFghcA>? NHXiXJRCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh2NkCgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD61NFEyQSEQvF2= MkC1NVk4PDR6NUi=
NCI-H522 M2jFSGZ2dmO2aX;uJIF{e2G7 NIfUOJc1QCCq NGf4VllCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh3MkKgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD6wNFIh|ryP Mlr3NVk4PDR6NUi=
COLO205 cells MWDGeY5kfGmxbjDhd5NigQ>? M4PZV|Q5KGh? M1S0UWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDU2xQOjB3IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTJwNUGxPFkh|ryP NHrOVnAyQTd2NEi1PC=>
HCC2998 cells NX;QbWx4TnWwY4Tpc44h[XO|YYm= MX60PEBp M1\KW2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR2MzQTl6IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTFwNUi0PFkh|ryP NFz3TGYyQTd2NEi1PC=>
HCT116 cells NGn6[ZdHfW6ldHnvckBie3OjeR?= NX\jU|doPDhiaB?= NYTWfod4SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhEXDFzNjDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCwNUDPxE1? MoLKNVk4PDR6NUi=
HCT15 cells MX7GeY5kfGmxbjDhd5NigQ>? MYi0PEBp NXH1TllsSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhEXDF3IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMUK1PFkh|ryP MljzNVk4PDR6NUi=
HT-29 cells M3G2TmZ2dmO2aX;uJIF{e2G7 MYO0PEBp NFPnOnRCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTHQuOjliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS57OUWyOkDPxE1? NUO4NIFMOTl5NES4OVg>
KM12 cells MmjQSpVv[3Srb36gZZN{[Xl? M3fxZ|Q5KGh? NFnTPG9CdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gT20yOiClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0zNjVzMUi5JO69VQ>? MlLrNVk4PDR6NUi=
SW620 cells M3zTPGZ2dmO2aX;uJIF{e2G7 MoCzOFghcA>? M1roNmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTW|YzOCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF03NjNyOUW3JO69VQ>? NV7nU2RKOTl5NES4OVg>
SF268 cells NUXaOnd7TnWwY4Tpc44h[XO|YYm= MWW0PEBp NIqzeWhCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV2YzPjhiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OTBizszN NUH5UWp3OTl5NES4OVg>
SF295 cells NVrRPG9tTnWwY4Tpc44h[XO|YYm= MVu0PEBp M1zQVWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTSlI6PSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjBzMkW5JO69VQ>? NFj2O3oyQTd2NEi1PC=>
SF539 cells MlzlSpVv[3Srb36gZZN{[Xl? Moe5OFghcA>? MkXJRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPGOVM6KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODN7OEGg{txO NWrWe3RFOTl5NES4OVg>
SNB19 cells NYjU[FViTnWwY4Tpc44h[XO|YYm= MoW4OFghcA>? NXrRSo43SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNPSjF7IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTFwOUm1NlYh|ryP M3OxWlE6PzR2OEW4
SNB75 cells M4TUN2Z2dmO2aX;uJIF{e2G7 M3LEU|Q5KGh? M{\NbGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTUmI4PSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjF7OUWzJO69VQ>? M1\CcFE6PzR2OEW4
U251 cells M2PMNGZ2dmO2aX;uJIF{e2G7 MWm0PEBp MVfBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVUK1NUBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlEzPTh7IN88US=> NGfkeHcyQTd2NEi1PC=>
LOXIMVI cells NG\Sd5BHfW6ldHnvckBie3OjeR?= MY[0PEBp NEPIdohCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUG9ZUU2YSTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCyOVEzKM7:TR?= NIX0UVMyQTd2NEi1PC=>
MALME-3M cells NX75cnRrTnWwY4Tpc44h[XO|YYm= MonnOFghcA>? MlXrRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3BUG1GNTOPIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTdwOUSzNlgh|ryP MkfSNVk4PDR6NUi=
M14 cells MknLSpVv[3Srb36gZZN{[Xl? MYm0PEBp MWfBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTUG0JINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNVU5PDlizszN NVe0dXJxOTl5NES4OVg>
SK-MEL-2 cells NYXacI1uTnWwY4Tpc44h[XO|YYm= NILBW241QCCq NUTn[pV[SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD2yJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUGwJO69VQ>? MXyxPVc1PDh3OB?=
SK-MEL-28 cells MXTGeY5kfGmxbjDhd5NigQ>? MnjROFghcA>? NXj4c2NQSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD2yPEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlk6PTJ4IN88US=> NULYTWFROTl5NES4OVg>
SK-MEL-5 cells NFmyXnhHfW6ldHnvckBie3OjeR?= Mo\yOFghcA>? NYfPV2FESW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD21JINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNVk6PTNizszN M1;PdVE6PzR2OEW4
UACC257 cells MVnGeY5kfGmxbjDhd5NigQ>? NVTqZmNrPDhiaB?= NYnjV4lYSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHVCS0N{NUegZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;Mz6xOlIzQCEQvF2= M{TzdVE6PzR2OEW4
UACC62 cells NGXy[IxHfW6ldHnvckBie3OjeR?= NH32bHQ1QCCq MlPnRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGXBR2M3OiClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjB|OUixJO69VQ>? NHvGSZQyQTd2NEi1PC=>
IGROV1 cells M2LGbmZ2dmO2aX;uJIF{e2G7 MmfaOFghcA>? MlTjRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFnHVm9XOSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0zNjVzMUi5JO69VQ>? NVLZUVJQOTl5NES4OVg>
OVCAR-3 cells NH\rSohHfW6ldHnvckBie3OjeR?= NXHYTGRJPDhiaB?= MWfBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iT2\DRXIuOyClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0zNjVzMUi5JO69VQ>? MnTnNVk4PDR6NUi=
OVCAR4 cells M3;MUmZ2dmO2aX;uJIF{e2G7 NXi1ZY9DPDhiaB?= NX;4V4pRSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG9XS0GUNDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1zMDFOwG0> M3jPSlE6PzR2OEW4
OVCAR5 cells NIXCb5RHfW6ldHnvckBie3OjeR?= MXq0PEBp M3X2b2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDPWmNCWjViY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:Pi5|MEm1O{DPpG1? NUnYc4U2OTl5NES4OVg>
OVCAR8 cells MVfGeY5kfGmxbjDhd5NigQ>? MWi0PEBp Moq1RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF;WR2FTQCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjF{NUi5JO69VQ>? NHvYSHkyQTd2NEi1PC=>
SKOV3 cells NXn2[GJUTnWwY4Tpc44h[XO|YYm= M2nWPFQ5KGh? MVvBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1vPWlMh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NU46QTV{NjFOwG0> MWCxPVc1PDh3OB?=
786-0 cells NHrObXpHfW6ldHnvckBie3OjeR?= NYC0fW9KPDhiaB?= NYi3c21USW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJFc5Pi1yIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMTFOwG0> MmnJNVk4PDR6NUi=
A498 cells M33lO2Z2dmO2aX;uJIF{e2G7 M1zqelQ5KGh? MVrBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUS5PEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlI2QDl|IN88US=> M37VWFE6PzR2OEW4
ACHN cells Ml3QSpVv[3Srb36gZZN{[Xl? M2PUUFQ5KGh? M{jQUGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBR2hPKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODNzNkKg{txO MXyxPVc1PDh3OB?=
Caki1 cells NWfBVZNTTnWwY4Tpc44h[XO|YYm= NFLJcZo1QCCq M121U2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDZYtqOSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjB|MU[yJO69VQ>? NXfYNW1yOTl5NES4OVg>
SN12C cells NViwTJdMTnWwY4Tpc44h[XO|YYm= MUm0PEBp NXXDV5dWSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNPOTKFIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMUm5OVMh|ryP NIjKcmMyQTd2NEi1PC=>
TK10 cells NH;ubGhHfW6ldHnvckBie3OjeR?= MkTlOFghcA>? NXTiO41ESW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHRMOTBiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:PS5yMUG4O{DPxE1? MoH3NVk4PDR6NUi=
UO31 cells MULGeY5kfGmxbjDhd5NigQ>? Ml;uOFghcA>? MmHnRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGXPN|Eh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yOjV6OTFOwG0> NWLpfIZNOTl5NES4OVg>
PC3 cells MnjHSpVv[3Srb36gZZN{[Xl? MoLYOFghcA>? Mn\2RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlMyPjJ|IN88US=> NV;LW5NnOTl5NES4OVg>
DU145 cells Mme5SpVv[3Srb36gZZN{[Xl? MVK0PEBp NUXScHBLSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGRWOTR3IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMkWxNVkh|ryP MlzhNVk4PDR6NUi=
MCF7 cells MUPGeY5kfGmxbjDhd5NigQ>? NUTGeVE6PDhiaB?= MXrBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlAxPjNzIN88US=> NYfRTHJqOTl5NES4OVg>
NCI/ADR-RES cells M{nB[mZ2dmO2aX;uJIF{e2G7 MmnrOFghcA>? MXnBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTlPJM2FFWi2URWOgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MT6yOVg6OyEQvF2= M4PQVVE6PzR2OEW4
MDA-MB-231 cells MlPxSpVv[3Srb36gZZN{[Xl? MoDSOFghcA>? NIHn[JBCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUWRCNU2ELUKzNUBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2zMlk5OTB5IN88US=> NHH5WYkyQTd2NEi1PC=>
Hs 578T cells MXrGeY5kfGmxbjDhd5NigQ>? MUC0PEBp NV;qT3ZNSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGh{KDV5OGSgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;Mz65PFExPyEQvF2= MkDrNVk4PDR6NUi=
MDA-MB-435 cells NXrmTo02TnWwY4Tpc44h[XO|YYm= NUT5flVTPDhiaB?= MmjIRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi12M{WgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;Mz6xOlIzQCEQvF2= MoPINVk4PDR6NUi=
MDA-N cells Ml33SpVv[3Srb36gZZN{[Xl? NHjXbJo1QCCq MnXTRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1PKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVEvOjV6OUOg{txO NELFR3MyQTd2NEi1PC=>
BT549 cells M{X6SGZ2dmO2aX;uJIF{e2G7 MnnqOFghcA>? MUDBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQmS1OFkh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NUDPxE1? Mne5NVk4PDR6NUi=
T47D cells NE\iSpNHfW6ldHnvckBie3OjeR?= MlHEOFghcA>? NXL5bZkzSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHQ1P0RiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS5{NUi5N{DPxE1? MVWxPVc1PDh3OB?=
HepG2 cells NWjMRodWS3m2b4TvfIlkcXS7IHHzd4F6 NYfTUlUxPzJiaB?= NFf5NI9EgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\XCJMjDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVE5Njh2IN88US=> NVjDdmVwOTl7MUe1Nlg>
A549 cells Mn;yR5l1d3SxeHnjbZR6KGG|c3H5 M1XEPVczKGh? NE\mOYlEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEWFNUC9PU44PCEQvF2= NGnFTGYyQTlzN{WyPC=>
LAC cells NX;ifpd1S3m2b4TvfIlkcXS7IHHzd4F6 M{LtVlczKGh? NIPr[4REgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBNSUNiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhTUN3ME2zNk4xQSEQvF2= MoTZNVk6OTd3Mki=
HeLa cells MYrDfZRwfG:6aXPpeJkh[XO|YYm= Mn;QO|IhcA>? NGTLbmFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEWFNUC9NVAvOjZizszN MX6xPVkyPzV{OB?=
MDA-MB-231 cells M{PLNGN6fG:2b4jpZ4l1gSCjc4PhfS=> MWfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IH;2[ZJmgHC{ZYPzbY5oKHW{b3vpcoF{\SCybHHzcYlvd2enbjDhZ5RqfmG2b4KsJGlEPTB;MD6yNUDPxE1? NVz0OotMOjB|NkOxN|A>
human ACHN cells NGjpfndHfW6ldHnvckBie3OjeR?= M3fLe2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBR2hPKGOnbHzzJIJ6KFOUQjDhd5NigSxiR1m1NF0zNjFizszN MlKwNlA4OzJ6MUC=
PC3 cells NIPTeXhHfW6ldHnvckBie3OjeR?= MXjBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHL5JHNTSiCjc4PhfUwhT0l3ME20Mlk4KM7:TR?= M1zFZVIxPzN{OEGw
MDA-MB-231 cells MUnGeY5kfGmxbjDhd5NigQ>? MoCyRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYomgV3JDKGG|c3H5MEBIUTVyPUCuNVYh|ryP MVeyNFc{OjhzMB?=
FM3A cells Mom0SpVv[3Srb36gZZN{[Xl? NGn4SZozKGSjeYO= MnfBR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JI1wfXOnIF\NN2Eh[2WubIOgZYZ1\XJiMjDkZZl{KGK7IHPveYx1\XJiY3;1cpRqdmdiYX7hcJl{cXNuIFnDOVA:OC5yMEm0JO69VQ>? NUW2[WZROjF|M{CwNVQ>
HeLa cells NHfjdnNHfW6ldHnvckBie3OjeR?= MYDDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSHXMZUBk\WyuczDpckBxemW|ZX7j[UBw\iB{MDD1UUB1cHmvaXTpcoUtKEmFNUC9PE42KM7:TR?= M{P1[FIyOzNyMEG0
LLC cells M33k[WN6fG:2b4jpZ4l1gSCjc4PhfS=> M1TaUlI1KGh? NHjBTHlEgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBNVENiY3XscJMh[W[2ZYKgNlQhcHK|IHL5JJJme2G8dYLpckBie3OjeTygTWM2OD1zND6yJO69VQ>? NIjtZXMzOTV|NkS0PC=>
LLC cells M1HrWWN6fG:2b4jpZ4l1gSCjc4PhfS=> NWmzO|VqPzJiaB?= NFviR5REgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBNVENiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JJJme2G8dYLpckBie3OjeTygTWM2OD1{IN88US=> MoTVNlE2OzZ2NEi=
RAW264.7 cells NHTke3VEgXSxdH;4bYNqfHliYYPzZZk> NITU[2E4OiCq MmD0R5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgVmFYOjZ2LkegZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KHKnc3H6eZJqdiCjc4PhfUwhUUN3ME2zNEDPxE1? MXGyNVU{PjR2OB?=
A549 cells MnnFR5l1d3SxeHnjbZR6KGG|c3H5 NVvIW3lxPzJiaB?= NI\5NpJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KGG|c3Xzd4VlKGG|IHPlcIwhfmmjYnnsbZR6KGGodHXyJFczKGi{czDifUBYW1RvODDhd5NigSxiSVO1NF0xNjB2NzFOwG0> NH3DZmIzOjJ2OEi1Oi=>
A2780 cells M4X5R2N6fG:2b4jpZ4l1gSCjc4PhfS=> NEXVXoY2KGSjeYO= MlX1R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVI4QDBiY3XscJMh[W[2ZYKgOUBl[Xm|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlAzPiEQvF2= MkjBNlI4Ozh4M{[=
LMTK cells NXrrO4M5S3m2b4TvfIlkcXS7IHHzd4F6 NWTqXolkPSCmYYnz MWnDfZRwfG:6aXPpeJkh[WejaX7zeEB1cHmvaXTpcoUhc2mwYYPlMYRm\mmlaXXueEBud3W|ZTDMUXRMKGOnbHzzJIFnfGW{IEWg[IF6eyCkeTDNWHQh[XO|YYmsJGlEPTB;ND61JO69VQ>? MX2yNlc{QDZ|Nh?=
A549 cells M3XnZWN6fG:2b4jpZ4l1gSCjc4PhfS=> M1j4dFczKGh? M3P1O2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGE2PDliY3XscJMh[W[2ZYKgO|IhcHK|IHL5JI1q[3KxcHzheIUhemWjZHXyJI1mfGixZDygTWM2OD1yLkCxNlQh|ryP MViyNlg1PzBzOR?=
CEM cells NF6yNXNHfW6ldHnvckBie3OjeR?= M1HEUlczKGh? MlrFR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPFUUBk\WyuczDlfJBz\XO|aX7nJIh2dWGwIFXOWFEhfHKjboPwc5J1\XJiYX\0[ZIhPzJiaILzJIJ6KGOnbHygZ492dnSrbnegbY4heHKnc3XuZ4Uhd2ZiTlLNVHItKEmFNUC9NE45KM7:TR?= MVKyNVg6Ojh{OR?=
Hela cells NVjscodNTnWwY4Tpc44h[XO|YYm= NEDyb2k4OiCq NYTXeGNyS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGxiY3;1cpRqdmduIFnDOVA:OC5yNTFOwG0> MkfENlE5QTJ6Mkm=
CEM/0 cells MoT6SpVv[3Srb36gZZN{[Xl? MUG3NkBp MXHDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1XNM|Ah[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IHPlcIwh[2:3boTpcoctKEmFNUC9NE4xOjJizszN M2nEOFIyQDl{OEK5
L1210/0 cells NXPZU41sTnWwY4Tpc44h[XO|YYm= NVG3cIwzPDhiaB?= NVLhR4drS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KG2xdYPlJGwyOjFyL{CgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KGOnbHygZ492dnSrbnesJGlEPTB;MD6wNFA6KM7:TR?= MUWyNVg6Ojh{OR?=
MCF7 cells MUXDfZRwfG:6aXPpeJkh[XO|YYm= MXK3NkBp MlHoR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPUGyMlE6KM7:TR?= NH3XRXAzOzh4N{[wNy=>
HeLa cells NGTB[4hEgXSxdH;4bYNqfHliYYPzZZk> MkPMO|IhcA>? NEjkO2REgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KGGodHXyJFczKGi{czDifUBUWkJiYYPzZZktKEmFNUC9Ok42KM7:TR?= NEfqWIEzOzh4N{[wNy=>
HL60 cells NFPuUVFRem:uaX\ldoF1cW:wIHHzd4F6 NFu5SWI4OiCq MWXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiONkCgZ4VtdHNiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1yLkK0JO69VQ>? NVPBOZRmOjV4NES2O|Q>
SW707 cells NXHFOoRYWHKxbHnm[ZJifGmxbjDhd5NigQ>? M2XSUVczKGh? NWixfHNxSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTW|cxPyClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA4OiCqcoOgZpkhW1KEIH3leIhw\CxiSVO1NF0zOy56NjFOwG0> MYmyOVY1PDZ5NB?=
LoVo cells NHPBTplRem:uaX\ldoF1cW:wIHHzd4F6 NHvIR3g4OiCq MlXKRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCOb2\vJINmdGy|IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJIFnfGW{IEeyJIhzeyCkeTDTVmIhdWW2aH;kMEBKSzVyPUG5MlA4KM7:TR?= NH22VY8zPTZ2NE[3OC=>
BALB/3T3 cell NF3TOXZRem:uaX\ldoF1cW:wIHHzd4F6 NGnYPY04OiCq M2G5WGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViQlHMRk8{XDNiY3XscJMh[XO|ZYPz[YQh[XNiZ4Lve5RpKGmwaHnibZRqd25iYX\0[ZIhPzJiaILzJIJ6KFOUQjDt[ZRpd2RuIFnDOVA:OjNwOTFOwG0> MV6yOVY1PDZ5NB?=
HFF cells M1HlNGZ2dmO2aX;uJIF{e2G7 M4TCOVczKGh? M1:0d2FvfGmyYYLhd4l1cWNiYXP0bZZqfHliYXfhbY5{fCCWb4jvdIxie22jIHfvcoRqcSCDVFPDJFUxQDN7IHnu[oVkfGWmIHnuJGhHTiClZXzsd{Bi\nSncjC3NkBpenNiYomgZoV1[S2pYXzhZ5Rwe2mmYYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE46OSEQvF2= M{m4NVE4Pjl6NkG4
CCRFCEM cells Ml\5SpVv[3Srb36gZZN{[Xl? M2P2S2N6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDR3JHS0WPIHPlcIx{KGK7IF3UWEBie3OjeTygTWM2OD1yLkK5JO69VQ>? NHzpc2QyPzhyNEKzNS=>
RXF393 cells MmHZSpVv[3Srb36gZZN{[Xl? MoHQOFghcA>? NIHZcYVCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVnhHOzl|IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTNwOUixNFch|ryP MnHVNVk4PDR6NUi=
HL-60(TB) cells MmfNSpVv[3Srb36gZZN{[Xl? MlXpOFghcA>? MVrBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFytOlApXEJrIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMUm5OVMh|ryP NXTweIN7OTl5NES4OVg>
L1210 cells M{XEN2Z2dmO2aX;uJIF{e2G7 M3OwUlE2KG2rboO= MX;Jcohq[mm2aX;uJI9nKHSqeX3p[Jlt[XSnIIP5cpRp[XOnIHnuJI1wfXOnIFyxNlExKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[geJJqfGm3bTDy[Yxm[XOnIH\yc40hYzVvM1jd[IVwgHm3cnnkbY5mKGGodHXyJJBz\WmwY4XiZZRqd25iZn;yJFE2KG2rboOgZpkhdGmzdXnkJJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFnDOVA:OC5yMEC2JO69VQ>? NXLqWXA{OjF|M{CwNVQ>
Colo-357 cells NYLyXIxETnWwY4Tpc44h[XO|YYm= M1[yN|ExOCEQvF2= MljJNVUhdWmwcx?= MY\BZ5Rqfmm2eTDheEBOWlB3IHnuJIh2dWGwIFPvcI8uOzV5IHPlcIx{KGG|c3Xzd4VlKGG|IEWtSoRWVVBiYXPjeY12dGG2aX;uJIF1KDFyMDD1UUBi\nSncjCxOUBucW6| NFjaeVIzODl|MEGyNy=>
KB cells M3TVNWN6fG:2b4jpZ4l1gSCjc4PhfS=> Mm\XO|IhcA>? M2HzUGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGtDKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDTVmIh[XO|YYmsJGlEPTB;OD62PUDPxE1? NHXBZokzOzh4N{[wNy=>

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 49 mg/mL (199.03 mM)
Water 49 mg/mL (199.03 mM)
Ethanol 10 mg/mL (40.61 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 246.19
Formula

C9H11FN2O5

CAS No. 50-91-9
Storage powder
Synonyms Deoxyfluorouridine, FDUR, NSC 27640

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02529774 Not yet recruiting Resected Liver Metastases From Colorectal Cancer Ye Xu|Fudan University September 2015 Phase 2|Phase 3
NCT01938729 Active, not recruiting Intrahepatic Cholangiocarcinoma|Peripheral Cholangiocarcinoma|Cholangiolar Carcinoma|Cholangiocellular Carcinoma) (ICC) Memorial Sloan Kettering Cancer Center|Ohio State University|University of Texas Southwestern Medical Center|Washington University School of Medicine September 2013 Phase 1
NCT01862315 Recruiting Intrahepatic Cholangiocarcinoma|Peripheral Cholangiocarcinoma|Cholangiolar Carcinoma|Cholangiocellular Carcinoma Memorial Sloan Kettering Cancer Center|Ohio State University|University of Texas|Washington University School of Medicine May 2013 Phase 2
NCT01749397 Recruiting Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer National Cancer Institute (NCI) December 2012 Phase 1
NCT01692704 Completed Cholangiocellular Carcinoma University of Zurich April 2012 Phase 1|Phase 2
NCT01525069 Recruiting Cholangiocarcinoma|Liver Neoplasms Washington University School of Medicine April 2012 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Floxuridine | Floxuridine supplier | purchase Floxuridine | Floxuridine cost | Floxuridine manufacturer | order Floxuridine | Floxuridine distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID